Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of Modified Release Glipizide in Healthy Volunteers
NCT05159427Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Mar 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of glipizide, sponsored by University of Michigan. Primary endpoint: Area Under the Plasma Concentration-time Curve to infinite time at 78 hours. Started Mar 2022; status: completed.
02
Drugs
glipizide
Beyond the preview
Go deeper on NCT05159427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05159427.